- Home
- NNNN vs PACS Comparison
NNNN vs PACS Comparison
Compare NNNN & PACS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNNN
- PACS
- Stock Information
- Founded
- NNNN 2021
- PACS 2013
- Country
- NNNN Germany
- PACS United States
- Employees
- NNNN N/A
- PACS N/A
- Industry
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- PACS
- Sector
- NNNN Health Care
- PACS
- Exchange
- NNNN Nasdaq
- PACS Nasdaq
- Market Cap
- NNNN 2.2B
- PACS 2.1B
- IPO Year
- NNNN 2025
- PACS 2024
- Fundamental
- Price
- NNNN $23.92
- PACS $12.32
- Analyst Decision
- NNNN
- PACS Buy
- Analyst Count
- NNNN 0
- PACS 4
- Target Price
- NNNN N/A
- PACS $26.25
- AVG Volume (30 Days)
- NNNN 76.5K
- PACS 662.9K
- Earning Date
- NNNN 11-07-2025
- PACS 11-10-2025
- Dividend Yield
- NNNN N/A
- PACS N/A
- EPS Growth
- NNNN N/A
- PACS 82.80
- EPS
- NNNN 0.06
- PACS 0.68
- Revenue
- NNNN $8,185,146.00
- PACS $3,558,953,000.00
- Revenue This Year
- NNNN N/A
- PACS $28.62
- Revenue Next Year
- NNNN N/A
- PACS $16.94
- P/E Ratio
- NNNN $442.46
- PACS $18.51
- Revenue Growth
- NNNN 21.95
- PACS 205.08
- 52 Week Low
- NNNN $5.18
- PACS $7.50
- 52 Week High
- NNNN $55.65
- PACS $43.92
- Technical
- Relative Strength Index (RSI)
- NNNN 35.64
- PACS 46.94
- Support Level
- NNNN $26.05
- PACS $12.12
- Resistance Level
- NNNN $30.65
- PACS $13.09
- Average True Range (ATR)
- NNNN 2.72
- PACS 0.54
- MACD
- NNNN -0.11
- PACS -0.10
- Stochastic Oscillator
- NNNN 19.80
- PACS 24.81
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
About PACS PACS Group Inc. Common Stock
PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.